Literature DB >> 28619197

Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms.

Panpan Hao1, Fan Jiang2, Jing Cheng1, Lianyue Ma1, Yun Zhang3, Yuxia Zhao4.   

Abstract

Traditional Chinese medicine (TCM) has more than 2,000 years of history and has gained widespread clinical applications. However, the explicit role of TCM in preventing and treating cardiovascular disease remains unclear due to a lack of sound scientific evidence. Currently available randomized controlled trials on TCM are flawed, with small sample sizes and diverse outcomes, making it difficult to draw definite conclusions about the actual benefits and harms of TCM. Here, we systematically assessed the efficacy and safety of TCM for cardiovascular disease, as well as the pharmacological effects of active TCM ingredients on the cardiovascular system and potential mechanisms. Results indicate that TCM might be used as a complementary and alternative approach to the primary and secondary prevention of cardiovascular disease. However, further rigorously designed randomized controlled trials are warranted to assess the effect of TCM on long-term hard endpoints in patients with cardiovascular disease.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chinese herbal drugs; dyslipidemia; heart failure; hypertension; randomized controlled trials as topic; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2017        PMID: 28619197     DOI: 10.1016/j.jacc.2017.04.041

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  103 in total

Review 1.  Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenues.

Authors:  Worku Abebe
Journal:  EPMA J       Date:  2019-01-08       Impact factor: 6.543

Review 2.  Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and Prospective.

Authors:  Ting-Ting Luo; Yuan Lu; Shi-Kai Yan; Xue Xiao; Xiang-Lu Rong; Jiao Guo
Journal:  Chin J Integr Med       Date:  2019-04-02       Impact factor: 1.978

Review 3.  Herbs Used for the Treatment of Hypertension and their Mechanism of Action.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  Curr Hypertens Rep       Date:  2017-09-18       Impact factor: 5.369

4.  Classical Chinese Herbal Formulas in the Treatment of Coronary Heart Disease: A Narrative Review.

Authors:  Xin-Hui Lu; Jun Li
Journal:  Chin J Integr Med       Date:  2018-11-27       Impact factor: 1.978

5.  Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.

Authors:  Jiansong Fang; Chuipu Cai; Yanting Chai; Jingwei Zhou; Yujie Huang; Li Gao; Qi Wang; Feixiong Cheng
Journal:  Eur J Med Chem       Date:  2018-10-15       Impact factor: 6.514

6.  Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury.

Authors:  Lan Li; Yili Wang; Rui Guo; Sheng Li; Jingyu Ni; Shan Gao; Xiumei Gao; Jingyuan Mao; Yan Zhu; Pingli Wu; Hongjun Wang; Deling Kong; Han Zhang; Meifeng Zhu; Guanwei Fan
Journal:  J Control Release       Date:  2019-11-26       Impact factor: 9.776

Review 7.  Therapeutic Effects of Traditional Chinese Medicine on Cardiovascular Diseases: the Central Role of Calcium Signaling.

Authors:  Yuxin Li; Zhang Zhang; Sen Li; Tingting Yu; Zhaoqi Jia
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

8.  Exploring the Regulatory Mechanism of Modified Huanglian Maidong Decoction on Type 2 Diabetes Mellitus Biological Network Based on Systematic Pharmacology.

Authors:  Qi He; Tianqing Zhang; Bing Jin; Yonghe Wu; Jiamin Wu; Pu Gao; Shiwei Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-12       Impact factor: 2.629

9.  Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy.

Authors:  Lan Li; Jingyu Ni; Min Li; Jingrui Chen; Lifeng Han; Yan Zhu; Deling Kong; Jingyuan Mao; Yi Wang; Boli Zhang; Meifeng Zhu; Xiumei Gao; Guanwei Fan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Network Pharmacology-Based Systematic Analysis of Molecular Mechanisms of Dingji Fumai Decoction for Ventricular Arrhythmia.

Authors:  Yi Liang; Bo Liang; Xin-Rui Wu; Wen Chen; Li-Zhi Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.